Table 1.
Patients' baseline characteristics (LA: left atrial, NOACs: novel oral anticoagulants).
| Patients (n) | RG group (58) | CB group (40) | p value |
|---|---|---|---|
| Age (years) | 61 ± 9 | 59 ± 10 | ns |
| Female gender n (%) | 20 (34) | 13 (32.5) | ns |
| LA size (mm) | 42.1 ± 4.6 | 41.3 ± 4 | ns |
| Hypertension (%) | 30 (51%) | 17 (42.5) | ns |
| Type II diabetes (%) | 3 (5.1) | 2 (5) | ns |
| Coronary artery disease (%) | 7 (12) | 5 (12.5) | ns |
| Medication prior to ablation | |||
| Beta blockers (%) | 55 (95) | 40 (100) | ns |
| Propafenone (%) | 24 (41) | 12 (30) | ns |
| Sotalol (%) | 2 (3) | 0 (0) | ns |
| Amiodarone (%) | 2 (3) | 1 (2.5) | ns |
| Acenocoumarol (%) | 40 (69) | 29 (72.5) | ns |
| NOACs (%) | 5 (8.6) | 4 (10) | ns |